Nykode Therapeutics AS (OSL:NYKD)
Norway · Delayed Price · Currency is NOK 3.220
-0.050 (-1.53%)
Jun 4, 2026, 11:41 AM CET
Nykode Therapeutics AS Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -14.91 | -12.24 | -38.82 | -35.15 | -42.74 | -9.41 |
Depreciation & Amortization | 2.15 | 2.04 | 2.25 | 2.12 | 1.81 | 0.73 |
Stock-Based Compensation | 0.6 | -0.03 | 3.79 | 3.7 | 3.83 | 3.44 |
Other Operating Activities | -12.81 | -16.45 | -9.29 | -22.41 | -9.5 | -1.62 |
Change in Accounts Receivable | -1.66 | 0.07 | 1.41 | -26.59 | 22.43 | -7.17 |
Change in Accounts Payable | -1.21 | 0.4 | -2.56 | -2.77 | 2.28 | -0.66 |
Change in Unearned Revenue | -0.86 | -3.24 | -7.99 | -15.5 | 6.09 | 17.78 |
Change in Other Net Operating Assets | - | - | -0 | -0.03 | -4.89 | -1.94 |
Operating Cash Flow | -28.7 | -29.46 | -51.22 | -96.62 | -20.69 | 1.16 |
Operating Cash Flow Growth | - | - | - | - | - | -99.36% |
Capital Expenditures | -0.01 | -0.04 | -0.07 | -1.9 | -2.68 | -0.87 |
Investment in Securities | - | - | - | - | 10.04 | 11.35 |
Other Investing Activities | 3.18 | 3.55 | 7 | 8.94 | 3.68 | 0.27 |
Investing Cash Flow | 3.17 | 3.52 | 6.93 | 7.04 | 11.05 | 10.75 |
Long-Term Debt Repaid | - | -1.2 | -1.22 | -0.89 | -1.2 | -0.61 |
Net Debt Issued (Repaid) | -1.18 | -1.2 | -1.22 | -0.89 | -1.2 | -0.61 |
Issuance of Common Stock | - | - | - | 45.7 | 1.8 | 21.18 |
Common Dividends Paid | -32.28 | -32.28 | - | - | - | - |
Other Financing Activities | -0.11 | -0.12 | -0.18 | -0.22 | -0.24 | -0.13 |
Financing Cash Flow | -33.57 | -33.6 | -1.4 | 44.59 | 0.36 | 20.44 |
Foreign Exchange Rate Adjustments | 4.14 | 4.43 | -1.52 | 1.21 | -0.56 | 0.03 |
Miscellaneous Cash Flow Adjustments | - | - | - | - | -0 | - |
Net Cash Flow | -54.95 | -55.11 | -47.2 | -43.78 | -9.85 | 32.38 |
Free Cash Flow | -28.71 | -29.49 | -51.29 | -98.53 | -23.37 | 0.28 |
Free Cash Flow Growth | - | - | - | - | - | -99.84% |
Free Cash Flow Margin | -5163.31% | -6510.82% | -560.07% | -739.52% | -258.81% | 0.79% |
Free Cash Flow Per Share | -0.09 | -0.09 | -0.16 | -0.33 | -0.08 | 0.00 |
Cash Interest Paid | 0.11 | 0.12 | 0.18 | 0.22 | 0.24 | 0.13 |
Levered Free Cash Flow | -18.35 | -18.77 | -34.3 | -49.62 | -8.6 | 6.38 |
Unlevered Free Cash Flow | -18.28 | -18.7 | -34.18 | -49.48 | -8.45 | 6.46 |
Change in Working Capital | -3.72 | -2.77 | -9.15 | -44.88 | 25.91 | 8.01 |